No double standards for natural health products

Editorial

2011-11-15

(Press-News.org) Natural health products and medicinal foods should be subject to the same regulations as pharmaceutical drugs to ensure safety and efficacy, states an editorial in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/site/embargo/cmaj111739.pdf.

While pharmaceutical drugs are subject to rigorous evaluation and must provide significant evidence of their therapeutic effects and that the benefits outweigh risks, natural health products in Canada are not. Many contain active pharmacological substances that can have potent effects and interactions which should have warnings.

"The multibillion-dollar natural health products industry sells the perception that because its products are "natural," they must also be safe, such that comprehensive testing like that required for pharmaceuticals is not required," write guest author Dr. Stuart MacLeod with CMAJ editor Dr. Matthew Stanbrook and colleagues. "However, it is a near-universal truth that any substance that exerts a beneficial effect on a biological system will also have the potential for adverse effects."

Health Canada created the Natural Health Products Directorate 10 years ago, but the regulatory framework that governs it does not protect the consumer.

"All health claims for any product should be subject to a common set of regulations, starting with consistent and easily understood standards of evidence proportional to health risks and benefits," conclude the authors.

"Uniform regulations are the best way to protect consumers while still allowing choice."

### END

ELSE PRESS RELEASES FROM THIS DATE:

1 in 5 Americans has hearing loss

2011-11-15

Nearly a fifth of all Americans 12 years or older have hearing loss so severe that it may make communication difficult, according to a new study led by Johns Hopkins researchers and published in the Nov. 14 Archives of Internal Medicine. The findings, thought to be the first nationally representative estimate of hearing loss, suggest that many more people than previously thought are affected by this condition. Study leader Frank Lin, M.D., Ph.D., an assistant professor with dual appointments in both the Department of Otolaryngology-Head & Neck Surgery at the Johns Hopkins ...

Climate change in Africa's river basins could impede continent's farm transformation efforts

2011-11-15

Contact Michelle Geis 254-706-348-938 mgeis@burnesscommunications.com Burness Communications Additional contacts: Jonathon Rees 27-76-185-1827 Jonathon@proofcommunication.com Michael Victor 27-728-434-343 m.victor@cgiar.org Climate change in Africa's river basins could impede continent's farm transformation efforts Experts at global water forum warn climate shifts will increase water pressure on already-stressed Limpopo, Nile and Volta river basins, increase cross-border water conflicts Tshwane, South Africa -- Climate change could significantly ...

Parkinson's disease risk greater in those exposed to trichloroethylene

2011-11-15

A novel study in twins found that exposure to trichloroethylene (TCE) -- a hazardous organic contaminant found in soil, groundwater, and air -- is significantly associated with increased risk of Parkinson's disease (PD). Possibility of developing this neurodegenerative disease is also linked to perchloroethylene (PERC) and carbon tetrachloride (CCI4) exposure according to the study appearing today in Annals of Neurology, a journal published by Wiley-Blackwell on behalf of the American Neurological Association and Child Neurology Society. The National Institute of Neurological ...

Glioblastoma multiforme in the Dock

2011-11-15

Glioblastoma multiforme (GBM) is the most common malignant brain cancer in humans. Patients with GBM have a poor prognosis because it is a highly aggressive form of cancer that is commonly resistant to current therapies. A team of researchers -- led by Bo Hu and Shi-Yuan Cheng, at the University of Pittsburgh Cancer Institute, Pittsburgh -- has now identified a molecular pathway that drives the aggressive cancerous nature of a substantial proportion of glioblastomas; specifically, those that overexpress the protein PDGFR-alpha. This pathway could represent a new therapeutic ...

JCI online early table of contents: Nov. 14, 2011

2011-11-15

EDITOR'S PICK: Glioblastoma multiforme in the Dock Glioblastoma multiforme (GBM) is the most common malignant brain cancer in humans. Patients with GBM have a poor prognosis because it is a highly aggressive form of cancer that is commonly resistant to current therapies. A team of researchers — led by Bo Hu and Shi-Yuan Cheng, at the University of Pittsburgh Cancer Institute, Pittsburgh — has now identified a molecular pathway that drives the aggressive cancerous nature of a substantial proportion of glioblastomas; specifically, those that overexpress the protein PDGFR-alpha. ...

NIH-funded twin study finds occupational chemical exposure may be linked to Parkinson's risk

2011-11-15

A new research report contributes to the increasing evidence that repeated occupational exposure to certain chemical solvents raises the risk for Parkinson's disease. Researchers analyzed the occupational histories of twins in which one of the pair developed the neurodegenerative disorder, and assessed that twin's likelihood of exposure to six chemicals previously linked to Parkinson's. Of the six chemicals investigated, researchers concluded that two common chemical solvents, trichloroethylene (TCE) and perchloroethylene (PERC), are significantly linked to development ...

Lexington Nannies Gives Back

2011-11-15

Lexington Nannies, http://www.LexingtonNannies.com has partnered with Venice Family Clinic in Los Angeles to offer free childcare to cancer patients as of November 2011. Patients who need childcare while receiving treatment for chemo or other cancer related treatments will be referred to Lexington Nannies by the clinic. Brooke Barousse, the owner of Lexington Nannies, was inspired to find a way to give back after attending a fundraiser for the clinic and hearing the stories about the work they were doing. "Cancer in particular hits home in my family. I want to help ...

Insects offer clues to climate variability 10,000 years ago

2011-11-15

CHAMPAIGN, Ill. -- An analysis of the remains of ancient midges – tiny non-biting insects closely related to mosquitoes – opens a new window on the past with a detailed view of the surprising regional variability that accompanied climate warming during the early Holocene epoch, 10,000 to 5,500 years ago. Researchers at the University of Illinois and the University of British Columbia looked at the abundance and variety of midge larvae buried in lake sediments in Alaska. Midges are highly sensitive to summer temperatures, so changes in the abundance of different species ...

'Dark Girls' Multi-City Film Event Announced. Directors/Producers D. Channsin Berry and Bill Duke Take Their Provocative Documentary on the Road.

2011-11-15

"Dark Girls" Directors/Producers D. Channsin Berry and Bill Duke have officially announced the first leg of a ground-breaking nationwide tour playing exclusively in concert theatres; Oakland, California, November 17, 2011 and Atlanta, Georgia, November 19, 2011. The tour is being promoted by BAP Events. The directors, will conduct a 'Question and Answer' session after each screening. Berry explains, "The nature of the subject matter and the responses we have received from audiences makes it a perfect fit for this type of interactive event." Duke adds, ...

Some tumors contain factors that may block metastasis

2011-11-15

PHILADELPHIA -- Scientists are another step closer to understanding what drives tumor metastasis, as laboratory models suggest there are factors inside tumors that can slow their own growth. In a recent issue of Cancer Research, a journal of the American Association for Cancer Research, Raúl A. Ruggiero, Ph.D., a biological researcher at the division of experimental medicine at the National Academy of Medicine in Buenos Aires, Argentina, described this novel mechanism. Ruggiero and colleagues used bioanalytical methods of ion electrospray mass and tandem mass spectrometry ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC